scispace - formally typeset
K

Keren Hirsch

Researcher at Ben-Gurion University of the Negev

Publications -  6
Citations -  558

Keren Hirsch is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Cyclin D & Cyclin. The author has an hindex of 5, co-authored 6 publications receiving 513 citations.

Papers
More filters
Journal ArticleDOI

Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.

TL;DR: It is suggested that lycopene inhibits cell cycle progression via reduction of the cyclin D level and retention of p27 in cyclin E–cdk2, thus leading to inhibition of G1 CDK activities.
Journal ArticleDOI

Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation

TL;DR: It is suggested that allicin plays a major role in the antiproliferative effect of water-soluble garlic preparations and that this effect may be attributed to the ability ofallicin to transiently deplete the intracellular GSH level.
Journal ArticleDOI

Lycopene and other carotenoids inhibit estrogenic activity of 17β-estradiol and genistein in cancer cells

TL;DR: The results suggest that dietary carotenoids inhibit estrogen signaling of both 17β-estradiol and genistein, and attenuate their deleterious effect in hormone-dependent malignancies.
Journal ArticleDOI

Role of gene regulation in the anticancer activity of carotenoids

TL;DR: It is found that lycopene can synergize with other phytonutrients in the inhibition of cancer cell growth and is feasible to suggest that carotenoids and their oxidized derivatives interact with a network of transcription systems that are activated by different ligands at low affinity and specificity and that this activation leads to the synergistic inhibition of cell growth.
Book ChapterDOI

The Role of Tomato Lycopene in Cancer Prevention

TL;DR: This review will primarily address the mechanisms proposed for the cancer preventive activity of tomato lycopene, focusing on the induction of phase II enzymes and the inhibition of growth factors and sex hormones such as estrogens and androgens.